Cargando…

Severe COVID-19 in patients with hematological cancers presenting with viremia

Detalles Bibliográficos
Autores principales:	Michot, J.M., Hueso, T., Ibrahimi, N., Pommeret, F., Willekens, C., Colomba, E., Francis, S., Bayle, A., Cournède, P.H., Merad, M., Foulon, S., Albiges, L., Gachot, B., Barlesi, F., Soria, J.C., Ribrag, V., Griscelli, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275471/ https://www.ncbi.nlm.nih.gov/pubmed/34265373 http://dx.doi.org/10.1016/j.annonc.2021.07.002

Ejemplares similares

1639P Impact of COVID-19 on ongoing oncological and hematological treatment strategy
por: Bayle, A., et al.
Publicado: (2021)

1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center
por: Hauchecorne, M., et al.
Publicado: (2020)

Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
por: Pommeret, F., et al.
Publicado: (2021)

Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
por: Michot, J.-M., et al.
Publicado: (2020)

1617P Sustained cancer clinical trial activity during the COVID-19 pandemic
por: Bayle, A., et al.
Publicado: (2021)

Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French Hotspot
por: Sun, Roger, et al.
Publicado: (2021)

Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
por: Danlos, François-Xavier, et al.
Publicado: (2021)

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic
por: Bayle, Arnaud, et al.
Publicado: (2021)

Updates in the Treatment of Peripheral T-Cell Lymphomas
por: Saleh, Khalil, et al.
Publicado: (2021)

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013
por: Ribrag, Vincent, et al.
Publicado: (2015)

Bocavirus viremia
por: Sukkaromdee, Pathoom, et al.
Publicado: (2015)

Author Correction: The immuno-oncological challenge of COVID-19
por: Derosa, Lisa, et al.
Publicado: (2022)

Low-level residual viremia and risk of virological failure
por: Cologni, G, et al.
Publicado: (2010)

VIREMIA IN HUMAN POLIOMYELITIS
por: Horstmann, Dorothy M., et al.
Publicado: (1954)

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
por: Widera, Marek, et al.
Publicado: (2017)

BK viruria and viremia in children with systemic lupus erythematosus
por: Gupta, Nirupama, et al.
Publicado: (2017)

1694P Discovery of circulating biomarkers in COVID-19 patients undergoing anti-IL6R immunotherapy
por: Michot, J-M., et al.
Publicado: (2020)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

Duration of Zika Viremia in Serum
por: Fontaine, Albin, et al.
Publicado: (2018)

Permafrost viremia and immune tweening
por: Penhaskashi, Jaden, et al.
Publicado: (2023)

Hepatitis C virus RNA viremia in Central Africa.
por: Cancré, N, et al.
Publicado: (1999)

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia
por: Garrido, C, et al.
Publicado: (2010)

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
por: Hofstra, Laura Marije, et al.
Publicado: (2014)

Rotavirus Antigenemia in Children Is Associated with Viremia
por: Blutt, Sarah E, et al.
Publicado: (2007)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
por: van Duin, David, et al.
Publicado: (2011)

Residual Viremia in Treated HIV(+) Individuals
por: Conway, Jessica M., et al.
Publicado: (2016)

Bocavirus Viremia and Hepatitis in an Immunocompetent Child
por: Haytoğlu, Zeliha, et al.
Publicado: (2017)

BK Viremia Exacerbation With Adalimumab Coadministration
por: Lum, Erik L., et al.
Publicado: (2020)

Viremia in human Cowpox virus infection
por: Nitsche, Andreas, et al.
Publicado: (2007)

1025. Consequences of Low-level Viremia Among Women with HIV in the United States
por: Aldredge, Amalia, et al.
Publicado: (2023)

P1351: CHARACTERIZING ALLOGENEIC STEM CELL TRANSPLANTATION SAFETY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER PEMBROLIZUMAB THERAPY
por: Kuruvilla, J., et al.
Publicado: (2022)

Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?
por: Abdelwahab, Sayed F.
Publicado: (2016)

Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study
por: Cerbone, L., et al.
Publicado: (2021)

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
por: DUNCAN, Maggie C., et al.
Publicado: (2023)

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
por: Bigenwald, Camille, et al.
Publicado: (2023)

Astrovirus MLB2 Viremia in Febrile Child
por: Holtz, Lori R., et al.
Publicado: (2011)

Clinical consequences of persistent low level viremia
por: Dyner, Toby, et al.
Publicado: (2012)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
por: Hoffman, Risa M., et al.
Publicado: (2020)

Association of blood groups with hepatitis C viremia
por: Mahnoor, et al.
Publicado: (2021)

Anakinra/steroids: Cytomegalovirus viremia: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bfeo4i8vh1k0p2ndf0nga76i9h